Patents by Inventor Henri Stephen Lichenstein

Henri Stephen Lichenstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of nephritis using anti-PDGF-DD antibodies
    Publication number: 20040141969
    Abstract: Embodiments of the invention described herein relate to antibodies directed to platelet derived growth factor-DD (PDGF-DD) and uses of such antibodies. The antibodies of the invention find use as diagnostics and as treatments for diseases associated with the overproduction of PDGF-DD. In particular, in accordance with embodiments of the invention, the use of anti-PDGF-DD antibodies for the treatment of nephritis and related disorders, including diseases caused by mesangial proliferation is provided.
    Type: Application
    Filed: September 16, 2003
    Publication date: July 22, 2004
    Inventors: Juergen Floege, Gadi Gazit-Bornstein, Bruce A. Keyt, William J. LaRochelle, Henri Stephen Lichenstein
  • Afamin: a human serum albumin-like protein
    Patent number: 5767243
    Abstract: The invention relates to a novel human serum protein referred to as AFM, which has one or more activities in common with human serum albumin, human a-fetoprotein, or human vitamin D binding protein and which has an apparent molecular weight by SDS-PAGE of 87 kd; variants thereof; and related genes, vectors, cells and methods.
    Type: Grant
    Filed: March 13, 1997
    Date of Patent: June 16, 1998
    Assignees: Amgen Inc., The Rockefeller University
    Inventors: Henri Stephen Lichenstein, David Edwin Lyons, Mark Matsuo Wurfe, Samuel Donald Wright
  • Afamin: a human serum albumin-like gene
    Patent number: 5652352
    Abstract: The invention relates to a novel human serum protein and nucleic acid referred to as AFM, which has one or more activities in common with human serum albumin, human a-fetoprotein, or human vitamin D binding protein and which has an apparent molecular weight by SDS-PAGE of 87 kd; variants thereof; and related genes, vectors, cells and methods.
    Type: Grant
    Filed: March 31, 1994
    Date of Patent: July 29, 1997
    Assignees: Amgen Inc., The Rockfeller University
    Inventors: Henri Stephen Lichenstein, David Edwin Lyons, Mark Matsuo Wurfel, Samuel Donald Wright